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Abstract
Introduction: Sensitization to the Hymenoptera venom is one of the main causes of anaphylaxis in Poland. Venom immunotherapy 
is the only effective treatment in such cases. Comprehensive patient care includes also education. The aim of our study was to 
assess the state of knowledge and to evaluate the quality of life and the anxiety level in patients allergic to the Hymenoptera 
venom after anaphylactic reaction. 
Material and methods: The survey was carried out in the period of the insects flight in 61 adult subjects (35 wasp and 26 bee 
allergic), using a validated Vespid Allergy Quality of Life Questionnaire (VQLQ), Hospital Anxiety and Depression Scale, and sub-
jective assessment of anxiety level. The majority of respondents received venom immunotherapy. 
Results: Sensitized to the wasp venom had significantly impaired quality of life (VQLQ score) as compared to the bee venom 
allergic (p = 0.014). The intensity of anxiety decreased with the duration of immunotherapy (p = 0.01). The majority of subjects 
knew how to recognize and treat anaphylaxis, but only 8% employed an identification card and about 50% implemented rules of 
the pre-exposition prophylaxis. 
Conclusions: History of a severe anaphylaxis to the Hymenoptera venom affected the quality of life. Venom immunotherapy 
reduced anxiety. We hope that presented surveys and their results might be useful in qualifying for immunotherapy in clinically 
uncertain cases.
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Introduction
Ever since thinkers such as Hippocrates and 
Aristotle, thought was given to the foundation of 
happy and fulfilling life [1]. In modern decades, 
this issue again began to play an important role [2]. 
The concept of Health Related Quality of Life 
(HRQL) includes the following areas of life: physi-
cal condition, mental and spiritual states, social and 
economic conditions, and somatic sensations [2]. 
Until recently, in allergology, the quality of life 
was assessed only in patients with asthma, aller-
gic rhinitis and conjunctivitis, by examining the 
impact of disruptive clinical symptoms on the 
patient’s well-being. Although people allergic to 
the Hymenoptera venom have no signs of allergic 
disease, when not exposed to stings, however 
lack of symptoms does not mean the absence of 
impact on their lives. Here, the quality of life is 
influenced mainly by continuous anxiety and 
vigilance against repetitive stings and uncertainty 
of what will happen in the event of unexpected 
allergen exposure, including risk of brain damage, 
heart attack, or even sudden death [3, 4]. Fortu-
nately, the risk of death after Hymenoptera stings 
is not high, estimated at 0.09−0.45/1 million 
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inhabitants/year [5]. For most people allergic 
reaction to the Hymenoptera venom is a very 
traumatic experience [4]. During insect flight 
seasons these persons limit daily activities, give 
up their hobby, avoid certain places, such as 
grocery stores or bars, and reduce spending time 
outdoors. Despite being equipped with a set of 
“rescue” medications, including an epinephrine 
injection kit, patients report that they experi-
enced anxiety and even terror, when stinging 
insect appeared in the environment. 
A group of researchers from the Netherlands 
and Canada recently developed an innovative 
questionnaire for persons allergic to wasp ven-
om: the Vespid Allergy Quality of Life Question-
naire (VQLQ) [6, 7]. The Polish version of this 
questionnaire was developed by a team from the 
Medical University of Gdansk [8]. The Clinic of 
Allergy and Immunology in Krakow is one of 
the few centres in Poland that carry out accurate 
diagnosis of allergy in adults with a history of 
systemic reactions to stings, and subsequently 
apply specific venom immunotherapy (VIT), 
which is the only proven therapeutic method 
[5]. It should be applied in cases with a history 
of severe IgE-mediated anaphylactic reactions. 
Sometimes this treatment can be also considered 
after reactions to stings, which occurred as a gen-
eralized urticaria [9], or even (as recommended 
by the American Academy of Asthma, Allergy and 
Immunology) as recurrent large local reactions, 
as long as this condition significantly hinders 
the patient’s  life, especially with high-risk of 
repeated exposure to venom (eg. with relation to 
their professional activity), accompanied by the 
serious fear of repetitive stings [10]. Since the 
assessment of the life quality makes it possible to 
detect the person’s specific problems, and hence 
allows for an individual approach to the patient 
and for providing him with appropriate assis-
tance, a survey among patients with a history of 
anaphylactic reaction to the Hymenoptera venom, 
has been performed.
Material and methods
Patients
The study was conducted between May and 
October 2013, the flight season of Hymenoptera. 
All consecutive patients with a history of ana-
phylactic reaction after Hymenoptera stings were 
invited to complete the survey. In total, the study 
involved 61 adults: 35 with wasp venom and 26 
with bee venom allergy. 
Description of the survey
Each patient included in the study answered 
the questionnaire evaluating the quality of life, 
only once. The questionnaire consisted of two 
parts. The first part was filled by the patient with 
the help of the doctor or nurse. It had the form 
of a detailed allergology history. The second part 
of the questionnaire, which consisted of the Pol-
ish version of VQLQ and the Hospital Anxiety 
and Depression Scale (HADS) was completed 
by the patients independently. In addition, the 
survey included an analogue scale from “0” to 
“100”, which aimed to determine to determine 
the intensity of a current fear of the stings. There 
were also questions about some aspects of daily 
life, relationships with family, neighbours and 
friends, reflections on changing in work because 
of the sensitization and a request for an answer 
about, what the disease has changed the most in 
the patient’s life.
We received the original Polish version of the 
VQLQ questionnaire by the courtesy of Professor 
Marek Niedoszytko. The questionnaire contained 
14 questions. The first six questions referred to 
the symptoms of anxiety and the concerns related 
to the avoiding of stinging insects; the next eight 
questions examined the level of patients’ alertness 
during normal and specific life activities [6]. To 
each question 7 possible answers, reflecting the 
potential impact of allergy on patient life, have 
been prepared. The patient had to answer each 
question assigning scores from 1 (severe deterio-
ration) to 7 (no deterioration) [9]. Then the total 
number of points was counted and divided by 
the number of questions that is by 14. The final 
result of the arithmetic mean was interpreted as 
the result of the VQLQ questionnaire.
The HAD scale, was constructed by Zigmond 
and Snaith [9] and adapted for patients suffering 
from various somatic diseases. Its purpose is to 
assess the negative emotions in form of anxiety 
and depression in a population of patients with no 
psychiatric disorders. [9]. The scale in its original 
version consists of 7 items testing anxiety and, 7 
items relating to depressive states. The individual 
interpretation of this scale includes the following 
categories: 0−7 points — no disturbance; 8−10 
points — borderline states; 11−21 points — dis-
turbances [11, 12]. The Polish version of this 
research tool has also been made available to us 
by Professor Niedoszytko. 
On the analogue scale from “0” to “100” — “0” 
meant complete lack of fear or anxiety, and “100” 
— maximum fear and anxiety of further stings.
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Table 1. Demographic characteristics of the respondents
Allergic to wasp venom,
n = 35
Allergic to bee venom,
n = 26
p
Age: 
median, (interquartile range)
43 (36−54) 47 (39−61) NS
Gender: (women/men) 16/19 14/12 NS
Place of residence: urban/rural
n (%)
19 (54%)/16 (46%) 7 (27%)/19 (73%) 0.03
Education:
n (%)
primary: 3 (8,6%)
vocational: 12 (34%)
secondary: 9 (26%)
higher: 11 (31,4%)
primary: 1 (4%)
vocational: 4 (15%)
secondary: 10 (38,5%)
higher: 11 (42,5%)
Occupation:
n (%)
unemployed: 10 (28,6%)
office workers: 10 (28,6%)
physical workers (outdoors activities):  
13 (37,1%)
bee-keepers: 0
farmers: 2 (5,7%)
unemployed: 10 (38,5%)
office workers: 9 (34,6%)
physical workers (outdoors activities):  
5 (19,2%)
bee-keepers: 1 (3,8%)
farmers: 1 (3,8%)
Leisure activities:
n (%)
outdoors only: 8 (22,8%)
indoors only: 12 (34,3%)
indoors and outdoors: 15 (42.8%)
outdoors only: 12 (46,1%)
indoors only: 5 (19,2%)
indoors and outdoors: 9 (34,6%)
NS — non-significant
In addition, patients were questioned in de-
tails about their health education state regarding 
anaphylaxis and their compliance with specific 
safety rules in everyday life, in order to avoid 
unwanted exposure to the venom. This element 
of the study was not only of cognitive value, but 
first of all increased the respondents’ current 
knowledge.
The survey was begun having obtained a pos-
itive opinion of the Jagiellonian University Bio-
ethics Committee.
Statistical analysis
The StatSoft STATISTICA 10.0 software was 
used for statistical calculations. The normality of 
numerical data distribution was defined with the 
use of the Shapiro-Wilk test. The distribution oc-
curred to be non-normal; therefore Tables showed 
the median and the interquartile range. Differ-
ences between the individual groups of subjects 
were calculated with the use of the U-Mann-Whit-
ney test. Distribution of demographic data and 
compliance with the rules prior to exposure to 
Hymenoptera venom was compared using the 
chi-square test. The linear regression model was 
employed to assess the effect of co-morbidities, 
complications during VIT, duration of VIT, and 
patients’ education on the intensity of anxiety 
and VQLQ score, as well as effect of education 
level on the compliance with relevant rules of 
pre-exposition prevention.
The level of p < 0.05, was assumed to be 
statistically significant.
Results
Table 1 shows demographic data of respon-
dents according to the allergy type. Groups did 
not differ with regard to age and gender. People 
allergic to the wasp venom lived both in rural 
and urban areas, while those with an allergy to 
bee venom lived mainly in rural areas (p = 0.03). 
With the exception of 2 patients all respondents 
were already in the course of immunotherapy, 
of which 56% have been treated for more than 
two years, 15% from 0.5−1 year, 10% 1−2 years, 
and 19% have been desensitized for less than 6 
months (with no difference between wasp and 
bee allergy). More than half of the patients had no 
other co-morbidities, while the remaining were 
treated due to a concomitant disease: hyperten-
sion (23%), allergic rhinitis (13%) and asthma 
(6%). Family history of allergy to Hymenoptera 
venom in 82% of patients was negative.
The VQLQ questionnaire and the anxiety 
level (scale “0” to “100”)
Table 2 shows the results of the VQLQ sur-
vey and the anxiety level measured on a scale 
from “0” to “100”. In allergic to the wasp venom 
the VQLQ survey showed lower scores (poorer 
quality of life), than in bee allergic (p = 0.014). 
Such a relationship was not found for the anxiety 
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Table 2.  VQLQ score and anxiety level measured in the scale from “0” to “100”. The table shows the median and interqu-
artile range 
Women
n = 30
Men
n = 31
p Allergic to wasp venom,
n = 35
Allergic to bee venom, 
n = 26
p
VQLQ 4.57
(3.42−5.29)
5.29
(3.92−6.15)
NS 4.45
(3.22−5.75)
5.29
(4.71−6.17)
0.014
Anxiety 34.5 
(10−69.5)
15.0
(5−40)
NS 20.0
(10−69)
15.0
(5−39.5)
NS
NS — non-significant 
level. It has been shown that the vast majority of 
patients allergic to the wasp venom, “every day in 
the summer would think about their allergy” and 
were “horrified at the possibility of further stings.” 
In the group of patients allergic to bee venom 
there was 2.5 × less of such people (p = 0.0004 
and p = 0.02, respectively). Half of the patients 
who were allergic to wasp venom admitted they 
“refrained from outdoor professional activities”, 
while there was twice less such persons in the 
bee venom allergic group (difference statistically 
non significant). A similar trend was observed 
in terms of planning holiday trips: slightly more 
of those allergic to wasp choose places free from 
stinging insects, and with easily accessible med-
ical facilities. In both groups, the majority of 
respondents would avoid direct sunlight, limit 
walking, cycling and practicing their favourite 
sport, for fear of possible stings.
The linear regression model showed that the 
severity of an anaphylactic reaction to stings in 
the past, complications of venom immunothera-
py, occasional stings occurring during VIT (27% 
declared such), co-morbidities, as well as the 
subjectively assessed by respondents themselves, 
knowledge on anaphylaxis, and the fact of being 
equipped with an emergency anaphylaxis kit, 
did not affect the patients’ level of anxiety on 
a scale from “0” to “100”, or the VQLQ result. 
The only factor affecting the severity of anxiety 
was the length of immunotherapy (p = 0.01, R2 
= 0.09), the longer the duration of VIT, the lower 
anxiety level. For the VQLQ only such trend was 
demonstrated (p = 0.09). On the other hand, local 
skin reactions after vaccine administration were 
important for the VQLQ (p = 0.01, R2 = 0.09), re-
ported as significantly higher negatively affected 
the VQLQ score.
The HAD scale
Among respondents in both groups the vast 
majority (76% and 75%) did not demonstrate any 
anxiety. 12% of patients allergic to wasp venom 
and 12.5% to bee venom demonstrated border-
line disorders and almost the same amount had 
significant disorders. According to the depression 
rating scale, respectively 94% and 91% of pa-
tients were within normal values. Border result 
indicating mild depression, was demonstrated in 
6% (allergic to wasp venom) and 9% (allergic to 
bee venom) of patients. None of the respondents 
demonstrated significant disturbances. Between 
patients allergic to the wasp and bee venom both 
in the assessment of anxiety and in the assess-
ment of depression, no statistically significant 
differences have been found on this scale. 
Knowledge about anaphylaxis  
and adherence to the principles  
of pre-exposition prevention
89% of respondents admitted to have at 
least once received accurate information on the 
symptoms, course and treatment of anaphylactic 
reaction to stings, of which only 76% indicated 
that this information helped them reduce fear and 
anxiety (with no difference between wasp and bee 
venom allergy). 51 respondents (83%) stated they 
carried an epinephrine emergency anaphylaxis kit 
and would use it if necessary (also no difference 
between the two groups). On the other hand, only 
5 patients (8%) carried some information if they 
were allergic (bracelet/card with a diagnosis). 
75% of respondents (the same in both groups) 
would be able to recognize the symptoms of an 
incipient systemic reaction. The most important 
factor with an impact on anaphylaxis knowledge 
degree, was the respondents’ level of education 
(lineal regression model, p = 0.005, R2 = 0.11). On 
the other hand, education did not affect either the 
VQLQ score, or the level of anxiety assessed on 
a scale “0” to “100”, nor did it affect compliance 
with relevant rules of pre-exposition prevention. 
A particularly interesting result was obtained in 
this part of the survey which analyzed insect ven-
om allergy, in terms of family relationships and 
the environment. Almost 90% reported that their 
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 Table 3.  Compliance with the safety behavior rules by patients, allergic to the wasp and bee venom during flight season 
of insects. The number and percentage of subjects adhering to the given principle in everyday life was shown  
in the table
Safety rule Allergic to wasp 
venom;
n (%)
Allergic to bee 
venom;
n (%)
p
1. I do not keep food in the open air 21 (60) 11 (42) NS
2. I avoid walking barefoot outdoors 16 (46) 10 (38) NS
3. I avoid accumulation of garbage close to the house 13 (37) 12 (46) NS
4. I eat fewer meals out in restaurants (bars, restaurants) 12 (34) 1 (4) 0.004
5. I eat fewer meals outdoors 12 (34) 2 (8) 0.01
6. I limit errands in open retail sites 11 (31) 1 (4) 0.007
7. I mount the net on the windows to prevent insects getting into the apartment 9 (26) 2 (8) NS
8. I do not use fragrances in the apartment 7 (20) 1 (4) NS
9. I pay attention to the colour of the clothes, avoiding intense and pastel colours 7 (20) 4 (16) NS
10. I try not to take out waste in the trash, another member of the family does it 6 (17) 2 (8) NS
11. I do not keep fresh flowers in the house 6 (17) 0 (0) 0.03
12. I consume less alcohol in the house or outside 4 (11) 1 (4) NS
13. I do not go barefoot around the house 6 (17) 4 (16) NS
14. I use less cosmetics fragrances 6 (17) 3 (12) NS
15. I avoid using public toilets 5 (14) 1 (4) NS
16. I choose complete clothes (long sleeve, long trousers, hat) 4 (11) 3 (12) NS
17. I avoid opening windows and doors 4 (11) 0 (0) NS
18. I use adhesive tape to attach insects 3 (9) 3 (12) NS
19. I do not hang laundry outside 1 (3) 0 (0) NS
20. I do not use scented laundry liquids 1 (3) 0 (0) NS
21. I choose shoes that cover the entire foot 1 (3) 3 (12) NS
NS — non-significant
closest family feared the next reactions to stings. 
The same number of patients claimed discussing 
their allergy with friends, but only 10% discussed 
the procedures in case of anaphylactic reaction 
with their family members and friends. In rela-
tions with neighbours, this percentage was even 
lower (6%). Also here, no statistical differences 
between the two groups were found.
Table 3 shows the results concerning com-
pliance with rules intended to avoid unwanted 
exposure to the venom. What draws attention is 
poor compliance in both groups.
To the question: “What has the disease 
changed the most in your life”, patients allergic 
to wasp venom placed as first, the need to comply 
with safety rules in order to avoid further stings, 
and as the second they mentioned reduction of 
the joy of life and withdrawal from life, and as the 
third — fear. Patients allergic to bee venom also 
mentioned as first, compliance with safety rules, 
the second was fear, but on the third place there 
was the need of change of professional activity or 
hobby (with a statistically significant difference 
compared to patients allergic to wasp venom).
Discussion
Hypersensitivity to Hymenoptera venom 
with a history of severe anaphylactic reaction 
adversely influenced the quality of further life. 
In our study, this observation referred more to 
wasp allergy, what is probably associated with 
the biological behaviour and wide spread of 
these insects in both rural and urban areas. It is 
also important that the intensity of fear of fur-
ther stings decreased along with the duration of 
venom immunotherapy. Therefore, appropriate 
treatment (VIT), not only protected patients from 
the potential risk of anaphylaxis and death after 
the stings, but also significantly reduced the anx-
iety level. This is another argument for an urgent 
qualification and immediate implementation of 
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desensitisation therapy for all those, who meet 
the eligibility criteria for VIT. On the other hand, 
in patients with confirmed IgE-mediated allergy 
to insect venom and an uncertain clinical histo-
ry (eg. isolated urticaria or unclear anaphylaxis 
course) documented assessment of life quality and 
of subjective fear, can be an important element 
of verification when considering comprehensive 
indications for VIT. It has not been shown so far, 
that carrying epinephrine reduces anxiety and 
improves the quality of life in these patients [14]. 
Moreover, in patients with a particularly severe 
sense of threat implementing intensive educa-
tional activities, recommending following pre-ex-
position prevention rules, and in some cases 
providing support from a clinical psychologist, 
would be advisable. We hope that the results of 
our survey, especially those demonstrating anxi-
ety intensity, and the VQLQ scores, will be useful 
for sites wishing to implement this element of 
comprehensive patient care in cases of allergy to 
insect venom. So far, only several such studies 
have been conducted both in Poland and in the 
world [7, 8, 13]. The quality of life of our respon-
dents as assessed with the VQLQ questionnaire 
seems to be better than in an analysis carried out 
by a team from Gdansk, in patients before the start 
of VIT, but very similar to the results obtained in 
patients after one year of desensitization therapy 
[8]. Similar VQLQ scores have been obtained by 
a Dutch team in patients prior to desensitization 
treatment who demonstrated only cutaneous 
reactions to the wasp venom [9].
Family history of allergy to insect stings in 
a great majority of our patients was negative. Mul-
tiple stings have not been shown to be a risk fac-
tor for a more severe anaphylactic reaction (data 
not presented). These findings remain in line 
with the contemporary state of knowledge [15]. 
As shown in the results section, better educated 
persons, scored higher, as regards knowledge 
about anaphylaxis, but this did not affect their 
quality of life, severity of anxiety, or better 
compliance with pre-exposition prevention 
principles. On the other hand, however, despite 
oral and written recommendations, as much as 
20% of respondents did not carry the emergen-
cy epinephrine anaphylaxis kit during insect 
flight season, and only 5 of the 61 patients car-
ried information about their allergies. It is also 
important that the majority of respondents did 
not comply with the fundamental principles of 
pre-exposition prevention rules and some rules 
were not applied at all by any of the respondents 
(Table 3). This reflects the lack of knowledge 
and indicates the need for further education 
(especially of the less educated) while visiting 
the allergist office. Comprehensive care for pa-
tients with allergy to insect stings must therefore 
take into account not only the specific immu-
notherapy, but also include efforts to increase 
knowledge of both the patient and relatives of 
the patient’s environment (family, friends). Very 
few of our respondents discussed the principles 
of proper behaviour in the case of an anaphy-
lactic reaction to stings with their friends or 
colleagues. The study respondents admitted 
that they “did not want to scare” their relatives 
by their allergy and also pointed to the fear of 
social stigma. However, it cannot be excluded 
that people from the close environment who in 
the event of severe anaphylactic reaction would 
adopt emergency anaphylaxis procedures. 
Our study points to the need of drawing spe-
cial attention to people who are allergic to insect 
stings to changing their daily routine during 
insect flight seasons in terms of pre-exposition 
prevention. The most important of these recom-
mendations are presented in Table 3. It appears 
that such guidance should also be communicated 
to a wider social group, including those non-aller-
gic, as healthy behaviours, aiming at avoiding of 
unwanted exposure with the risk of insect venom 
allergy development. Support from the media e.g. 
series of short TV programs or websites presenting 
issues of pre-exposition prevention with regard to 
natural behaviour of stinging insects, would be 
of help. The dynamic growth in the number of 
anaphylactic reactions in the last decade, where 
wasp, bee, hornet or bumblebee stings account 
for about 50% of these complications, should 
lead to taking measures for health promotion 
with this regard.
Limitation of the study 
Presented study has also several limitations. 
First of all, the number of subjects is low. In 
a  situation, when only a  few responders gave 
a positive answer to the questions raised, the 
epidemiological inference is obviously impossi-
ble. Besides that, recruited patients were at the 
different stage of VIT, what caused that the group 
was heterogeneous. Nevertheless, we believe that 
the given below conclusions are truthful. 
Conclusions
The history of an anaphylactic reaction in 
people allergic to the insect venom negatively 
affects the quality of life. Immunotherapy sig-
nificantly reduces the severity of anxiety in these 
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cases. It seems that the proposed surveys may be 
useful when qualifying patients for immunother-
apy in clinically uncertain cases.
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